NCT06874868

Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder

Assessment of Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: University of Coimbra · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

t is recognized that cortisol, a hormone produced by the adrenal glands, is a marker that is elevated in patients with psychological disorders, particularly anxiety. On the other hand, Temporomandibular Disorders (TMD) are a condition with a multifactorial etiology, in which emotional disturbances play a crucial role. Therefore, the aim of this study is to evaluate whether patients with TMD have higher levels of salivary cortisol compared to the general population. Initially, an assessment will be conducted using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) protocol to determine whether the patient suffer of any kind of Temporomandibular Disorder. Based on the results, individuals will be classified into two groups: the study group, consisting of patients with TMD, and the control group, composed of individuals without the disorder. Those who agree to participate will be required to sign an informed consent form. Subsequently, a saliva sample will be collected for analysis.

Conditions

• Temporomandibular Joint Disorder

Timeline

• Start date: 2024-09-15
• Primary completion: 2024-09-20
• Completion: 2025-05-30
• First posted: 2025-03-13
• Last updated: 2025-03-13

Locations

1 site across 1 country: Portugal